STRO vs SIFY Comparison

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Sify Technologies Ltd is the integrated information and communication technology (ICT) solutions and services companies in India, offering end-to-end solutions with a comprehensive Product offering delivered over a common network infrastructure. It is providing services to enterprise customers, comprising Network services, Data Center services, and Digital Services which represent its operating segments. Majority of revenue comes from Network services segment which focuses India Network Business, World'wide Network Business, Wholesale Voice, Retail Voice. Network services offers Secure Connect, Express Connect, Partner Connect, Data Center/Cloud Interconnect portfolio services. It has presence in India, and Rest of world. It generates maximum revenue from India.